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Abstract
Background: The human genome contains at least 18 genes for Nudix hydrolase enzymes. Many
have similar functions to one another. In order to understand their roles in cell physiology, these
proteins must be characterised.
Results: We have characterised two novel human gene products, hAps1, encoded by the NUDT11
gene, and hAps2, encoded by the NUDT10 gene. These cytoplasmic proteins are members of the
DIPP subfamily of Nudix hydrolases, and differ from each other by a single amino acid. Both
metabolise diadenosine-polyphosphates and, weakly, diphosphoinositol polyphosphates. An
apparent polymorphism of hAps1 has also been identified, which leads to the point mutation S39N.
This has also been characterised. The favoured nucleotides were diadenosine 5',5"'-pentaphosphate
(kcat/Km = 11, 8 and 16 ×  103M-1s-1 respectively for hAps1, hAps1-39N and hAps2) and diadenosine
5',5"'-hexaphosphate (kcat/Km = 13, 14 and 11 ×  103M-1s-1 respectively for hAps1, hAps1-39N and
hAps2). Both hAps1 and hAps2 had pH optima of 8.5 and an absolute requirement for divalent
cations, with manganese (II) being favoured. Magnesium was not able to activate the enzymes.
Therefore, these enzymes could be acutely regulated by manganese fluxes within the cell.
Conclusions: Recent gene duplication has generated the two Nudix genes, NUDT11 and NUDT10.
We have characterised their gene products as the closely related Nudix hydrolases, hAps1 and
hAps2. These two gene products complement the activity of previously described members of the
DIPP family, and reinforce the concept that Ap5A and Ap6A act as intracellular messengers.
Background
In addition to the canonical ribonucleoside and deoxyri-
bonucleoside phosphates and cofactors, cells contain a
large number of minor nucleotides. Among these are the
diadenosine polyphosphates (ApnA, where n = 2–7 [1]).
Ap3A and Ap4A are the most intensively studied of these
and are generally present in the soluble fraction of eukary-
otic and prokaryotic cells at concentrations between 10
nM and 5 µM [2]. Platelet dense granules, adrenal chro-
maffin granules and certain synaptic vesicles have been re-
ported to contain high concentrations of Ap5A and Ap6A
in addition to Ap3A and Ap4A, all of which can be exocy-
tosed following appropriate stimuli and bind to target cell
purinoceptors causing a variety of physiological responses
in the cardiovascular and central and peripheral nervous
systems [1,3–5]. However, although Ap6A has been de-
tected in erythrocytes [6], there are no substantiated meas-
urements of Ap5A and Ap6A in the soluble fraction of
nucleated cells, and it is likely that they are typically
present at concentrations much lower than those of Ap3A
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and Ap4A. The estimated 7 µM Ap5A reported in cardiac
muscle [7] may also be confined to granules.
Whilst the extracellular diadenosine polyphosphates have
partially characterised signalling properties, the possible
functions of the soluble, intracellular compounds remain
unclear. On the one hand, they may simply be by-prod-
ucts of several enzymic reactions (e.g. those catalysed by
aminoacyl-tRNA synthetases and other ligases [8]). On
the other, they may have one or more of a number of im-
portant regulatory roles, including involvements in DNA
replication/repair, metabolic stress responses, the deter-
mination of cellular fate, and the regulation of enzyme ac-
tivities and ion channels (see [1]). For example, Ap5A is a
potent inhibitor of adenylate kinase [9].
It is clear that cells have a variety of relatively specific en-
zymes able to degrade these compounds. These include
symmetrically-cleaving Ap4A hydrolases (in prokaryotes),
members of the histidine triad protein family such as the
FHIT tumour suppresser protein and (in lower eukaryo-
tes) the related Ap4A phosphorylases, and most wide-
spread of all, members of the Nudix hydrolase family (see
[10,11] for reviews). Nudix hydrolases cleave predomi-
nantly the diphosphate linkage in compounds of general
structure: nucleoside diphosphate linked to another moi-
ety, X. Some family members have a relatively broad sub-
strate specificity, while others have a much more restricted
range. They all possess the Nudix sequence signature mo-
tif Gx5Ex5 [UA]xREx2EexGU (where U is an aliphatic hy-
drophobic amino acid), which represents the catalytic site
of the enzyme. Animal and plant Ap4A hydrolases (EC
3.1.6.17) degrade Ap4A, Ap5A and Ap6A, always produc-
ing ATP as one of the products. They are most active to-
wards Ap4A; however, the related enzymes from
Escherichia coli [12] and Rickettsia prowazekii [13] show a
marked preference for Ap5A.
More recently, distinct members of the Nudix family that
prefer Ap6A have been purified and characterised. The
three human enzymes termed diphosphoinositol
polyphosphate phosphohydrolases 1 [14,15], 2α  and 2β
[16] (hDIPP-1, -2α  and -2β ) as well as Schizosaccharomyces
pombe Aps1 [17] and Saccharomyces cerevisiae Ddp1p [18]
all favour Ap6A over Ap5A. Activity with Ap4A is lower,
and is in fact lacking in the case of Ddp1p. Remarkably
these Ap6A hydrolases are also able to utilise the structur-
ally unrelated non-nucleotide substrates, diphosphoi-
nositol pentakisphosphate (PP-InsP5) and bis-
diphosphoinositol tetrakisphosphate ([PP]2-InsP4),
hence they are commonly referred to as the DIPP subfami-
ly. These substrates are generally favoured in vitro, with
kcat/Km ratios being 50–500-fold higher for PP-InsP5
compared to Ap6A, except for DIPP-2β , which has a signif-
icantly reduced relative activity with PP-InsP5 compared
to the others. The intracellular levels of diphosphoinositol
polyphosphates appear to be lower than those of the nu-
cleotide substrates. PP-InsP5 levels are often between 1
[19] and 3% [20,21] of the levels of InsP6, which has been
estimated as being between 15 and 100 µM (see [22]) and
[PP]2-InsP4 levels are an order of magnitude lower
[20,21], and as such are virtually undetectable in many
cell types. PP-InsP5 turnover is regulated by the tumour
promoter thapsigargin [19], while [PP]2-InsP4 turnover is
regulated by cyclic AMP- and cyclic GMP-dependent proc-
esses via an undefined mechanism [23]. However, as for
the ApnAs, no clear functions have yet been found for the
diphosphoinositol polyphosphates, although they have
been implicated in vesicle trafficking [24], apoptosis [25]
and DNA repair [26].
We describe here two further members of the human
DIPP subfamily with novel properties. These proteins,
hAps1 and hAps2, products of the NUDT11 and NUDT10
genes respectively, closely resemble the other DIPPs in
primary structure, but show a selectivity towards Ap5A
and Ap6A and reduced activity towards PP-InsP5 and
[PP]2-InsP4. They also display a novel pattern of tissue-
specific expression.
Results
Sequence alignment
An initial BLAST search of the GenBank expressed se-
quence tag (EST) database with the hDIPP-1 sequence
identified two closely related but previously uncharacter-
ised predicted proteins, which we have called hAps1 and
hAps2 (human ApsixA hydrolases 1 and 2). Alignment of
the cDNA sequences with the human genome indicated
that the genomic sequences encoding these proteins,
FLJ10628 and LOC139770, lie about 150 kb apart on the
X chromosome at Xp11.23 and are transcribed in oppo-
site directions (Fig. 1). In accordance with the guidelines
for the Nudix protein family, the genes for hAps1 and
hAps2 have been designated NUDT11 and NUDT10 re-
spectively by the HUGO Gene Nomenclature Committee
(see  [http://www.gene.ucl.ac.uk/nomenclature/gene-
family/npym.html]). These proteins are each 164 amino
acids long and are most similar to hDIPP-2β , hAps1 show-
ing 76, 90 and 91% identity at the amino acid level to
hDIPP-1, 2α  and 2β , respectively. In particular, they both
possess the additional Gln residue (Q86 in DIPP-2β ) that
distinguishes hDIPP-2β  from hDIPP-2α  and hDIPP-1 and
which is responsible for the reduced activity of hDIPP-2β
towards diphosphoinositol polyphosphates compared to
the other DIPPs. hAps1 and hAps2 are also identical to the
hDIPP-2 enzymes throughout the Nudix motif (Fig. 2).
These observations led us to anticipate that hAps1 and
hAps2 would be potent dinucleoside polyphosphate hy-
drolases with reduced activity towards diphosphoinositol
polyphosphates. The existence of two such similar ex-BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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pressed gene products was surprising. Comparison of the
open reading frames (ORFs) of hAps1 and hAps2 revealed
6 differences at the nucleotide level, leading to five silent
changes (T8, E28, E69, D88 and stop), and an Arg-Pro
substitution at position 89. A comparison of the cDNAs
for the two gene products showed further divergence in
the 3' untranslated region. It appears that the evolution of
these closely related genes occurred recently, as hAps1 and
hAps2 show greater similarity with each other than with
the Aps-like sequences from mouse (of which two genes,
XM_135784 and XM_135786 appear to yield the same
protein product) or cow (Fig 3). Further examination of
all available hAps1 ESTs revealed a sequence divergence,
leading to a point mutation S39N, in the coding region.
This is present in two ESTs (Table 1) and was detected in
10% (3 from 30) of polymerase chain reaction (PCR)
products generated from a range of normal human cDNA
samples from diverse sources. In all other respects investi-
gated, including the 3' untranslated region, it appeared to
be identical to hAps1. This would suggest that this minor
variant, hAps1-39N, represents a polymorphism present
in the human population. Its properties were also exam-
ined in this study.
Purification and properties of hAps1 and hAps2
The ORFs for hAps1, hAps1-39N and hAps2 were cloned
into the pGEX6P-1 expression vector and expressed in Es-
cherichia coli (E. coli). After incubation with isopropyl β -
D-thiogalactoside (IPTG) (100 µM) at 26°C for 8 hours, a
major protein of the expected size was induced and ex-
pressed in a soluble form in each case. The glutathione S-
transferase (GST)-tagged recombinant proteins were puri-
fied by chromatography on Glutathione Sepharose 4 Fast
Flow resin (Fig. 4).
Initially, the ability of hAps1 and hAps2 to metabolise
Ap5A was determined at 37°C in the presence of 50 mM
HEPES, pH 7.6 and 100 µM substrate. A divalent cation
was essential for activity, with Mn2+ by far the most effec-
tive between 2 and 6 mM (Fig. 5a). Cu2+ supported less
than 30% and Zn2+ and Co2+ each less than 3% of the
maximum activity. Ni2+, Ca2+ and, surprisingly, Mg2+
were unable to activate hAps1 or hAps2. When assayed in
the presence of 1 mM MnCl2, hAps1 and hAps2 showed
alkaline pH optima of pH 8.5 (Fig. 5b), a feature common
among Nudix hydrolases. Activity increased from unde-
tectable at pH 6 to over 70% maximum between 7.5 and
9. Previous characterisation of hDIPP-1, 2α  and 2β , as
well as S. pombe Aps1 was performed in a buffer contain-
ing 1 mM MnCl2 at pH 7.6. In order to compare results for
hAps1 and hAps2 directly with hDIPP-1, hDIPP-2 and S.
pombe Aps1, we have performed assays using identical
conditions.
When hAps1, hAps1-39N and hAps2 were assayed with a
wide range of potential substrates all three proteins were
found, as expected, to metabolise Ap5A and Ap6A. Of the
other substrates tested, only p4A and p4G showed signifi-
cant rates of hydrolysis by all three, while Ap4A and Gp4G
were also effective substrates for hAps2. All three enzymes
showed a marked preference for adenine over guanine nu-
cleotides. Table 2 shows rates of metabolism and products
formed where identified. Km and kcat values for each en-
zyme with Ap5A and Ap6A are shown in Table 3. The most
rapidly metabolised substrate appeared to be Ap5A, al-
though Ap6A was bound with higher affinity.
Prolonged treatment of Ap6A and Ap5A identified the ma-
jor products as adenosine 5'-monophosphate (AMP) plus
Figure 1
The NUDT11/NUDT10 region of chromosome Xp11.23. The two known exons of NUDT11, encoding hAps1, and
NUDT10, encoding hAps2 are shown represented as boxes. Introns are represented by angled connecting lines. The coding
region of each gene is shaded. Solid arrows indicate the direction of transcription of each gene.
150kB
NUDT11 NUDT10
Telomere Centromere
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adenosine 5'-pentaphosphate (p5A) and AMP plus adeno-
sine 5'-tetraphosphate (p4A) respectively. In neither case
did p5A or p4A accumulate as these are metabolised al-
most as rapidly as they are formed, p5A being hydrolysed
sequentially to p4A then ATP. In this respect, hAps1 and
hAps2 show similar modes of action to hDIPP-1 [15] and
hDIPP-2 (S.T. Safrany, data not shown). Nudix hydrolases
have been found to be sensitive to inhibition by fluoride.
Hydrolysis of Ap5A by hAps1 and hAps2 was found to be
inhibited non-competitively with Ki values of 13.0 ± 0.5
and 30 ± 1 µM respectively (data not shown).
Despite the overall high degree of sequence similarity be-
tween hAps1, hAps2 and the DIPPs, hAps1 and hAps2
were found to have little activity towards PP-InsP5 or
[PP]2-InsP4. hAps1 and hAps1-39N showed first order
rate constants (k-1) with PP-InsP5 of 19 ± 4 and 7 ± 5 µg-
1min-1 respectively. Activity of hAps2 was similar to that
of hAps1, with a k-1 = 13 ± 6 µg-1min-1. These compare
with  k-1 values of 2200, 2000 and 220 µg-1min-1 for
hDIPP-1, -2α  and -2β  respectively [16]. Km and kcat values
were determined for each of the proteins (Table 3) and
these suggested that the reduction in activity towards PP-
InsP5 compared with hDIPP-1 and hDIPP-2α  was prima-
rily due to a reduced affinity for this substrate. Activity to-
wards [PP]2-InsP4 was even weaker. hAps1 and hAps2
gave k-1 = 1.0 ± 0.2 and 0.9 ± 0.2 µg-1min-1 respectively.
hAps1-39N showed no activity towards [PP]2-InsP4 under
the conditions tested. In contrast, hDIPP-1, -2α  and -2β
gave k-1 values of 320, 90 and 32 µg-1min-1 respectively,
whereas S. pombe Aps1 and S. cerevisiae Ddp1p showed
similar activity with k-1 = 8.3 and 1.7 µg-1min-1 respective-
ly [15].
Tissue distribution
Analysis of the tissue distribution of hAps1 and hAps2
gene expression was performed using PCR and human tis-
sue cDNA samples. Using primers selective for hAps1,
Figure 2
Sequence alignment of hAps1, hAps2, hDIPP-1 and hDIPP-2 (α  and β ). The figure shows an alignment of the amino
acid sequences of hAps1, hAps2, hDIPP-1 and hDIPP-2 (α  and β ), generated by the MAP algorithm. Black shading denotes
amino acids in at least two of the proteins were identical. Physicochemical similarity is denoted by grey shading.
hAps1 1 -MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPG
hAps2 1 -MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPG
hDIPP-1 1 MMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPS
hDIPP-2α 1 MMKFKPNQTRTYDREGFKKRAACLCFRSEQEDEVLLVSSSRYPDQWIVPGGGMEPEEEPG
hDIPP-2β 1 MMKFKPNQTRTYDREGFKKRAACLCFRSEQEDEVLLVSSSRYPDQWIVPGGGMEPEEEPG
hAps1 60 GAAVREVYEEAGVKGKLGRLLGVFEQNQDRKHRTYVYVLTVTELLEDWEDSVSIGRKREW
hAps2 60 GAAVREVYEEAGVKGKLGRLLGVFEQNQDPKHRTYVYVLTVTELLEDWEDSVSIGRKREW
hDIPP-1 61 VAAVREVCEEAGVKGTLGRLVGIFE-NQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREW
hDIPP-2α 61 GAAVREVYEEAGVKGKLGRLLGIFE-NQDRKHRTYVYVLTVTEILEDWEDSVNIGRKREW
hDIPP-2β 61 GAAVREVYEEAGVKGKLGRLLGIFEQNQDRKHRTYVYVLTVTEILEDWEDSVNIGRKREW
hAps1 120 FKVEDAIKVLQCHKPVHAEYLEKLKLGGSPTNGNSMAPSSPDSDP---------------
hAps2 120 FKVEDAIKVLQCHKPVHAEYLEKLKLGGSPTNGNSMAPSSPDSDP---------------
hDIPP-1 120 FKIEDAIKVLQYHKPVQASYFETLRQGYSANNGTPVVATTYSVSAQSSMSGIR-------
hDIPP-2α 120 FKVEDAIKVLQCHKPVHAEYLEKLKLGCSPANGNSTVPSLPDNNALFVTAAQTSGLPSSV
hDIPP-2β 121 FKVEDAIKVLQCHKPVHAEYLEKLKLGCSPANGNSTVPSLPDNNALFVTAAQTSGLPSSV
hAps1 -
hAps2 -
hDIPP-1 -
hDIPP-2α 180 R
hDIPP-2β 181 RBMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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Figure 3
Comparison of hAps1 with translated EST sequences from mouse and cow. No full-length bovine EST for the hAps1
homologue is available, hence the composite of two separate sequences is shown. A predicted rat protein from genomic
sequencing is also shown.
Table 1: Tissue sources of known ESTs for hAps1 and hAps2
Tissue hAps1 hAps2
Brain 15434059a, hippocampus, hAps1 15936725, medulla
15495588, hypothalamus, hAps1 13980266, hypothalamus
15743679, pooled brain
Testis 14001386, hAps1 14083118
Breast 15996913, hAps1
Ovary 19353207, hAps1 18780184
Uterus 11970540, tumour cell line, hAps1
Eye 19049709, hAps1
Teratocarcinoma 7022778, 10989803, hAps1-39N
aNumbers are GenBank gene identifiers
hAps1             1 MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPGG
Mus7670416        1 MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPDG
rattus20162808    1 MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPDG
bos12124678       1 MKCKPNQTRTYDPEGFKKRAACLCFRSEREDEVLLVSSSRYPDRWIVPGGGMEPEEEPGG
bos6842189        1 ------------------------------------------------------------
hAps1            61 AAVREVYEEAGVKGKLGRLLGVFEQNQDRKHRTYVYVLTVTELLEDWEDSVSIGRKREWF
Mus7670416       61 AAVREVYEEAGVKGKLGRLLGVFEQNQDRKHRTYVFVLTVTELLEDWEDSVSTGRKREWF
rattus20162808   61 AAVREVYEEAGVKGKLGRLLGVFEQNQDRKHRTYVFVLTVTELLEDWEDSVSIGRKREWF
bos12124678      61 AAVREVFEEAGVKGKLGRLLGIFEQNQDRKHRTYVYVLTVTEILEDWEDSVTIGRKRV--
bos6842189        1 --------------------------QDRKHRTYVYVLTVTEILEDWEDSVSIGRKREWF
hAps1           121 KVEDAIKVLQCHKPVHAEYLEKLKLGGSPTNGNSMAPSSPDSDP
Mus7670416      121 KIEDAIKVLQCHKPVHAEYLEKLKLGGSPTNGNSAAPSPPESEP
rattus20162808  121 KIEDAIKVLQCHKPVHAEYLEKLKLGGSPTNGNSAAPSPPESEP
bos12124678         --------------------------------------------
bos6842189       35 KVEDAIKVLQCHKPVHAEYLQKLKLGGSPTNGNSVAPSPPEGDPBMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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PCR products were readily visible from brain, pancreas
and testis and less so from lung, thymus, prostate, ovary,
small intestine and heart (the least) (Fig. 6). Selective
primers for hAps2 produced strong signals from brain and
liver, but also from heart, placenta, lung, kidney, pancre-
as, spleen, prostate, testis and ovary (Fig. 6). No signal for
hAps1 was detected in placenta, liver, skeletal muscle, kid-
ney, spleen, colon or peripheral blood leukocytes. Like-
wise, no signal for hAps2 was found in skeletal muscle,
thymus, small intestine, colon or peripheral blood leuko-
cytes. A number of tumour cell line cDNA samples were
also tested; hAps1 was present in prostate PC3, and ovary
GI-102 cells. The prostate PC3 cell line was also found to
express hAps2. Tumour cell lines from breast GI-101, lung
LX-1, colon CX-1, lung GI-117, colon GI-112 and pancre-
as GI-103 were found to express neither hAps1 nor hAps2.
These results are in broad agreement with the sources of
ESTs for these two protein families (Table 1). This list is
for comparison and is not exhaustive. In contrast, hDIPP-
1 was found in all the tissues and cell types tested above
(S.T. Safrany, unpublished data).
Whilst an exhaustive analysis has not been performed for
hDIPP-2, it was found to be highly expressed in heart,
skeletal muscle, kidney and pancreas, and weakly ex-
pressed in brain, placenta lung and liver [16].
Subcellular localisation
The subcellular localisation of hAps1, hAps1-39N and
hAps2 was investigated by individual expression of the
three proteins tagged at the N-terminus with EGFP in
HEK293 and PC12 cells, and visualisation of the ex-
pressed fusion proteins by deconvolved fluorescence mi-
croscopy. These results show that in both cell types EGFP-
tagged proteins showed a cytosolic location indistinguish-
able from EGFP-hDIPP-2α , EGFP-hDIPP-2β  and EGFP
alone (Fig. 7a and 7b). Similar data were obtained with
proteins tagged at the C-terminus with EGFP (data not
shown). This is in agreement with localisation predicted
using PSORTII.
Discussion
The human genome contains at least 18 Nudix genes, sev-
eral of which encode multiple products, and 9 Nudix hy-
drolases have been characterised so far to varying degrees
(see  [http://www.gene.ucl.ac.uk/nomenclature/gene-
family/npym.html]). These include hDIPP-1, hDIPP-2α
and hDIPP-2β , encoded by the NUDT3 (hDIPP-1) and
NUDT4 (hDIPP-2α  and hDIPP-2β ) genes, all of which hy-
drolyse both the higher order diadenosine polyphos-
phates and diphosphoinositol polyphosphates. In this
report, we describe the cloning and functional characteri-
sation of hAps1 and hAps2, two new members of the
DIPP subfamily with a novel pattern of expression and
substrate specificity. A polymorphism of hAps1 (hAps1-
Figure 4
SDS-PAGE of purified hAps1, hAps1-39N and hAps2.
GST-tagged hAps proteins were prepared as described
under "Materials and methods". Approximately 10 µg of (a)
hAps1, (b) hAps1-39N and (c) hAps2 were analysed by SDS-
PAGE. Purity was determined by Coomassie-blue staining a
4–12% Bis-Tris NuPage gel (Novex). Molecular weight stand-
ards (MultiMark multi-colored standards) were from Novex.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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39N) has also been found, its activity and localisation ap-
pearing broadly similar to those of hAps1. Unlike the oth-
er subfamily members, hAps1 and hAps2 show little
activity towards diphosphoinositol polyphosphates, both
gene products favouring diadenosine polyphosphates,
ApnA, where n = 5 or 6. In each case, Ap6A binds with
higher affinity than Ap5A, whereas the kcat for the latter is
greater. Given that no other PP-InsP5 hydrolase activity
was observed during the purification of rat hepatic DIPP
(most similar to hDIPP-1) and assuming that tissue ex-
pression and physiology are broadly conserved between
human and rat, these results would suggest that Aps-like
proteins do not contribute significantly to inositol phos-
phate metabolism.
Both hAps1 and hAps2 show typical Nudix hydrolase re-
quirements, namely an alkaline pH optimum in vitro and
a requirement for divalent cations [12]. An unusual fea-
ture of hAps1 and hAps2 is that they both require Mn2+
for activation, and that Mg2+ is without effect. Optimal
[Mn2+] is approximately 4 mM, which is in contrast to
that estimated for free intracellular [Mn2+] of below 0.5
µM [27]. Free [Mn2+] in our in vitro assays was not deter-
mined. It is well acknowledged that Mn2+ binds serum al-
bumin very tightly, but despite this we would anticipate
free [Mn2+] in the assays to be far in excess of intracellular
levels. It is known that the activity of metal ion-requiring
enzymes in different cellular compartments can be regu-
lated through the controlled trafficking of these ions and
therefore through the controlled access of these enzymes
to their required ions. This principle has been most thor-
oughly studied in the case of Ca2+[28], although analo-
gous observations have been made with Cu2+[29] and
Mn2+[30]. Since the [Mn2+] throughout the cell is known
to be non-uniform, the unusual requirement of the hAps
enzymes suggests a possible mechanism of regulation
through access to this ion.
Several biochemically distinct Ap5/6A hydrolases have
been described previously. S. pombe Aps1, S. cerevisiae
Ddp1p and hDIPP-1 and hDIPP-2 have all been shown to
metabolise Ap5A and Ap6A. The activities of hAps1 and
hAps2 towards Ap5A and Ap6A are comparable to hDIPP-
1, but their activities towards the diphosphoinositol
polyphosphates PP-InsP5 and [PP]2-InsP4 are greatly re-
duced, thus making them some 100–300-fold more selec-
tive towards Ap5A and Ap6A than hDIPP-1 or hDIPP-2. S.
pombe Aps1 and S. cerevisiae Ddp1p, the sole representa-
tives of the DIPP subfamily in the two yeast genomes, ap-
pear to favour the diphosphoinositol polyphosphates.
Their modes of action have been shown to differ from
their mammalian counterparts. The major products of
Ap6A hydrolysis by S. pombe Aps1 and S. cerevisiae Ddp1p
are ADP and p4A [17,18]. As with hDIPP-1 [15] and
hDIPP-2 (Safrany, data not shown), hAps1 and hAps2
produced AMP and p5A as major products. With Ap5A as
substrate, S. pombe Aps1 favoured the production of ADP
plus ATP, whereas S. cerevisiae Ddp1p favoured produc-
tion of AMP and p4A. In this respect hAps1 and hAps2 as
well as hDIPP-1 and hDIPP-2 resemble Ddp1p.
Due to the chromosomal proximity of Aps1 and Aps2,
and the greater degree of sequence identity with each oth-
er than with the Aps-like genes from mouse, rat or cow, it
seems likely that this gene pair has arisen as the result of a
recent gene duplication event on the short arm of the X
chromosome [31]. A popular view of the evolution of cat-
alytic motifs envisages the duplication of relatively non-
specific progenitors followed by adaptation to perform
special tasks, and the Nudix hydrolase motif appears to be
a good illustration of this process. The existence of multi-
ple forms of these enzymes would suggest that the diade-
nosine polyphosphates have significant biological
functions, with the specialised task of hAps1 and/or
hAps2 being the regulation of Ap5A and Ap6A levels.
Conclusions
Previously, the human DIPP family comprised hDIPP-1, a
ubiquitous enzyme able to hydrolyse both inositol phos-
phates and diadenosine polyphosphates, and hDIPP-2α
and -2β , which are predominantly diphosphoinositol
polyphosphate phosphohydrolases highly expressed in
heart, skeletal muscle, kidney and pancreas. We have now
identified two further members, hAps1 and hAps2, which
have high selectivity towards the diadenosine polyphos-
phates. The distinction between DIPP and ApnA hydrolase
activities reinforces the importance of Q86 in DIPP-2β
and the role of Q85 in hAps1 and hAps2. The addition of
this amino acid in hDIPP-2 has been previously shown to
have a substantial negative effect upon its activity towards
diphosphoinositol polyphosphates, whereas Ap5A hydro-
lase activity was increased. The expression of hAps1 and
hAps2 is also restricted. Of the tissues tested, only pancre-
as showed high levels of hDIPP-2 and hAps1, and only
heart showed high levels of hDIPP-2 and hAps2, although
ESTs were found suggesting that hDIPP-2 is expressed in
testis, ovary and prostate. The presence of hAps1 and
hAps2 in such a variety of tissues suggests that Ap5A and
Ap6A may have roles other than as secreted molecules. We
find that hAps1 is present in the pancreas, but there is no
suggestion that it is secreted. For this reason, hAps1 and
hAps2 are expected to control intracellular Ap5A and
Ap6A levels.
In conclusion, we have identified two human Nudix hy-
drolases that share a novel substrate specificity, metabolis-
ing predominantly Ap5A and Ap6A. These two gene
products complement the activity of previously described
members of the DIPP family, and reinforce the concept of
Ap5A and Ap6A acting as intracellular messengers.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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Figure 5
Properties of hAps1 and hAps2. (a) Mn2+-dependency of hAps1 (filled circles) and hAps2 (open circles) activity towards
Ap5A (100 µM). (b) pH dependency of hAps1 (filled circles) and hAps2 (open circles) activity towards Ap5A (100 µM).
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Materials and Methods
Materials
Ap4G, Ap5G and p4A were purchased from Jena Bio-
science, Jena, Germany. Other nucleotides were pur-
chased from Sigma. Non-radioactive PP-InsP5 was a kind
gift from J.R. Falck (University of Texas Southwestern
Medical Center, Dallas, TX, USA). [3H]-PP-InsP5 and
[3H]-[PP]2-InsP4 were prepared as previously described
[15].
Cloning and plasmid construction
PCR products corresponding to the hAps1 sequence were
amplified from a human testis library (Clontech), using
the primers SSD019 (5'-ggcaggatccaagtgcaaacccaaccagacg-
3') and SSD020 (5'-ggcaggatccttagggatcgctatctggcg-3')
(BamHI sites are underlined). PCR was carried out using a
HiFidelity Expand Kit (Roche), and the products cloned
into the vector pCR2.1TOPO (Invitrogen) and sequenced.
Surprisingly, three variant sequences were found (termed
hAps1, hAps1-39N and hAps2). These were subcloned as
BamHI fragments into the BamHI site of pGEX-6P1 (Am-
ersham Pharmacia Biotech) (starting at K2, to compare
with K3 of hDIPP-1 and hDIPP-2) and fully re-sequenced.
Table 2: Nucleotide substrate utilisation by hAps1, hAps1-39N and hAps2
Nucleotide Rate (nmol/min/µg) Major products
hAps1 hAps1-39N hAps2
Ap6A 0.25 ± 0.04 0.19 ± 0.01 0.28 ± 0.04 AMP + p5A
Ap5A 0.41 ± 0.05 0.37 ± 0.02 0.9 ± 0.1 AMP + p4A
Ap4A 0.02 ± 0.01 0.02 ± 0.01 0.09 ± 0.03 AMP + ATP
Ap3A0 0 0
Ap2A0 0 0
Gp5G 0.04 ± 0.02 0.02 ± 0.01 0
Gp4G 0.04 ± 0.02 0.04 ± 0.02 0.11 ± 0.04 GMP, GDP, GTP
Gp3G0 0 0
Gp2G0 0 0
Ap5G0 0 0
Ap4G0 0 0
p4A 0.07 ± 0.03 0.10 ± 0.03 0.13 ± 0.04 ATP
ATP 0 0.03 ± 0.02 0
ADP-ribose 0 0 0
ADP-glucose 0 0 0
dATP 0 0.07 ± 0.04 0
p4G 0.15 ± 0.05 0.21 ± 0.05 0.21 ± 0.03 GTP
GTP 0.02 ± 0.01 0.03 ± 0.01 0
GDP-glucose 0.01 ± 00 0
GDP-mannose 0 0 0
dGTP 0.05 ± 0.03 0.05 ± 0.03 0
dUTP 0.04 ± 0.03 0.05 ± 0.02 0
dTTP 0.05 ± 0.04 0.05 ± 0.03 0
CTP 0.03 ± 0.02 0.03 ± 0.02 0BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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Table 3: Kinetic parameters of hAps1, hAps1-39N and hAps2
Enzyme Substrate Km (µM) kcat (s-1) kcat/Km (103M-1s-1)
hAps1 Ap6A 13 ± 50 . 1 7  ± 0.04 13.1
Ap5A 37 ± 90 . 4  ± 0.1 10.8
PP-InsP5 (n = 2) 4 0.20 50
hAps1-39N Ap6A 11 ± 30 . 1 6  ± 0.02 14.5
Ap5A5 0   ± 10 0.4 ± 0.1 8.0
PP-InsP5 (n = 2) 0.3 0.09 290
hAps2 Ap6A 19 ± 10 . 2 0  ± 0.01 10.5
Ap5A5 0   ± 10 0.8 ± 0.2 16.0
PP-InsP5 1.3 ± 0.6 0.14 ± 0.02 110
Figure 6
Tissue distribution of hAps1, hAps2 and β -actin. PCR using human tissue first-strand cDNA as template was performed
with primers specific for β -actin and for hAps1 or hAps2. 35 cycles of amplification were used for β -actin, 40 cycles for hAsp1
and hAps2.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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The 3' nucleotide of SSD019 introduced a silent mutation
into hAps2, and was allowed to remain. Likewise, SSD020
also introduced a silent mutation into the stop codon of
hAps2. This was also allowed to remain. Vectors for the ex-
pression of Nudix hydrolase proteins fused to the C-termi-
nus of Enhanced Green Fluorescent Protein (EGFP) were
produced by ligating a cDNA encoding each protein as a
BamHI digestion fragment from the GST-fusion vectors
described above, into pEGFP-C1 (Clontech) previously
digested with BglII and BamHI.
Bioinformatics
Multiple sequence alignments were performed using MAP
and BoxShade, both run by EMBnet, Lausanne, Switzer-
Figure 7
Subcellular localisation of EGFP, EGFP-hDIPP-2 (α  and β ) and hAps1 and hAps2. Proteins fused to the C-terminus
of EGFP were expressed in (a) HEK293 or (b) PC12 cells for 24 h and visualised by fluorescence microscopy.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/20
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land. Blast searches of EST and genomic databases were
performed using the facilities provided by NCBI, Bethes-
da, MD, USA.
Expression and purification of hAps1, hAps1-39N and 
hAps2
Full-length hAps1, hAps1-39N and hAps2 were expressed
and purified from E. coli as GST-fusion proteins. Expres-
sion plasmids based on pGEX-6P1 were transformed into
E. coli strain BL21, and induced at 26°C overnight with
100 µM IPTG. Cells were harvested in buffer A (20 mM
Tris, 150 mM NaCl, 2 mM DTT, 0.1 mM EGTA, pH 7.5),
supplemented with 5 µg/ml leupeptin and 1 µg/ml apro-
tinin, and disrupted by sonication (3 ×  15s). Particulate
matter was removed by centrifugation. The supernatant
was applied to (and subsequently eluted from) a 5 mm ×
5 cm Glutathione Sepharose 4 Fast Flow column (Amer-
sham Pharmacia Biotech) at a flow rate of 1 ml/min. The
column was washed for 5 min with buffer A. Bound pro-
tein was eluted with a gradient generated by mixing buffer
A with buffer B (buffer A plus 25 mM glutathione, pH 7.5)
as follows: 0-10 min, 0-50% buffer B; 10-13 min, 100%
buffer B. Fractions containing pure hAps1, hAps1-39N or
hAps2 were supplemented with glycerol (10% v/v final),
and stored at -80°C.
Tissue distribution
The tissue distribution of hAps1 and hAps2 expression
was determined by PCR from human tissue cDNA sam-
ples (human cDNA panels, Clontech) and human cDNA
libraries (testis from Clontech, brain from Dr Peter Che-
ung of the MRC Protein Phosphorylation Unit, Wellcome
Trust Biocentre, Dundee, Scotland, UK). β -Actin-specific
and hAps1 and hAps2-specific primers were used. The
hAps1 primers were SSD049 (5'-cgtcttcgaacagaaccaggatcg-
3'), and SSD045 (5'-caaaagccacacacatggtgcc-3') and the
hAps2 primers were SSD050 (5'-cgtcttcgaacagaaccaggaccc-
3') and SSD046 (5'-gtgcaacaacctggagaatagtcattgta-3').
Primers SSD045 and SSD046 were selective for the 3' un-
translated regions of hAsp1 and hAsp2 respectively. β -Ac-
tin cDNA was amplified using β  AS (5'-
acactgtgcccatctacgaggg-3') and β  AA (5'ccttctgcatcctgtcag-
caatg-3'). PCR was carried out using a HiFidelity Expand
Kit (Roche), and cDNA samples from heart, brain, placen-
ta, lung, liver, skeletal muscle, kidney, pancreas (human
MTC panel I #K1420-1, Clontech), spleen, thymus, pros-
tate, testis, ovary, small intestine, colon, peripheral blood
leukocytes (human MTC Panel II #K1421-1, Clontech).
The following tumour cell lines were also tested: breast
GI-101, lung LX-1, colon CX-1, lung GI-117, prostate
PC3, colon GI-112, ovary GI-102 and pancreas GI-103
(human MTC Tumor Panel #K1422-1, Clontech).
Subcellular localisation
The subcellular localisation of hAps1, hAps1-39N and
hAps2 proteins fused to EGFP was investigated using
transfected HEK 293 epithelial cells and PC12 pheochro-
mocytoma cells. PC12 cells were grown in DMEM/5%
foetal bovine serum/5% horse serum. HEK293 were
grown in DMEM/10% foetal bovine serum. Both cell
types were grown on coverslips and transfected using Fu-
gene-6 (Roche) with expression vectors for each Nudix hy-
drolase fused to the C-terminus of EGFP. 24 hours after
transfection, cells were observed using a Leica inverted
stage fluorescence microscope and a Hamamatsu Orca
charge-coupled-device camera. Images were analysed us-
ing Improvision OpenLab deconvolution software.
Enzyme assays
For the analysis of nucleotide metabolism, assays were
performed as previously described [15], unless otherwise
stated. The UV-absorbing (260 nm) nucleotide reaction
products were analysed using a 4.6 ×  125 mm Partisphere
5 µm SAX HPLC column. Substrates and products were
eluted at 1 ml/min by the following gradient generated by
mixing water with buffer C (1.3 M (NH4)2HPO4, pH 4.8
with H3PO4): 0-5 min, 0% buffer C; 5-55 min, 0-50%
buffer C; 56-70 min, 0% buffer C. pH optima of recom-
binant enzymes were determined in a series of buffers
comprising 1 mM MnCl2, 100 µg/ml BSA and 15 mM
MES, 15 mM HEPES or 15 mM Tris (pH 6-9 with HCl or
NaOH). Divalent ion-dependency was determined in a
buffer comprising 50 mM HEPES, 100 µg/ml BSA, pH 7.6,
and 50 µM-10mM (where possible) divalent metal as the
chloride salt. Inositol phosphate metabolism was deter-
mined exactly as described previously [14]. Km and kcat
values were determined by hyperbolic regression analysis.
Authors' note
During the reviewing of this manuscript a paper was sub-
mitted and accepted in the Journal of Biological Chemis-
try (K Hidaka, JJ Caffrey, L Hua, T Zhang, JR Falck, GC
Nickel, L Carrel, LD Barnes, SB Shears: An adjacent pair of
human NudT genes on chromosome X are preferentially
expressed in testis and encode two new isoforms of di-
phosphoinositol polyphosphate phosphohydrolase. J Biol
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